Cara Therapeutics Announces Positive Topline Results from KOMFORT Phase 2 Trial of Oral…
– Study achieved primary endpoint of Worst Itch-Numeric Rating Scale score change from baseline at Week 8 (p=0.001) – – Onset of action seen at Week 1 and sustained through Week 8 – – Statistical significance achieved on the WI-NRS…